An ammonia gas leak at a pharmaceutical company in Padra taluka of Vadodara district late on Friday evening killed one person and left four others unconscious, police said Saturday. The incident ...

A 2020 STAT analysis found more than two-thirds of Congress receiving a check from pharmaceutical companies that year. More recent data from Open Secrets likewise confirms that a large majority of ...

Argus Research analyst Jasper Hellweg maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) yesterday. The company’s shares opened today at $17.99. According to TipRanks ...

OKYO Pharma (OKYO) has been notified that the CEO Gary Jacob has purchased 10,000 of the Company’s ordinary shares on NASDAQ at a price of $1.04 per share. The company said, “We have also been ...

Marianne Faithfull, British singer and Rolling Stones muse, dies at 78 How To Make White Clothes White Again Donald Trump's Approval Rating Now Higher Than in First Term When 1 Tank Defeated 22 ...

Please take note that the Company has been awarded a work contract by NHPC Limited (A Government of India Navratna Enterprise) for development of Rooftop Solar Power Projects on Buildings of NHPC ...

The active pharmaceutical ingredient includes vitamin B5 and the original B5. The polymeric materials include polybutylene succinate and Polyvinyl butyral products. The company was founded on ...

BILLIONAIRE Li Ka-shing’s port business in Panama said it’s committed to operating in the country, after local authorities launched an audit of the company amid concerns raised by US President Donald ...

Pharmaceutical companies are interested in AI because it has the potential to save them lots of time and money. According to a recent article published in the Journal Nature Medicine, successfully ...

In short, VersAI™ is much greener AI. It’s truly remarkable that a pharmaceutical company is at the forefront of developing fundamental new AI technology that outperforms industry titans like Google, ...

Amid tough biotech industry market conditions last year, investors and Big Pharma companies were more likely to make deals with later-stage biotechs. Local industry leaders say that could change ...